Alerta De Seguridad para REVEAL LINQ Insertable Heart Monitor

Según National Institute of Drugs and Food Surveillance (INVIMA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Colombia que fue producido por Medtronic, Inc. || Medtronic Europe S. A.R.L.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
  • Número del evento
  • Fecha
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
  • Notas adicionales en la data
  • Causa
    The manufacturer states that it has identified a problem with the sensitivity of an algorithm used in the (icms), which may prematurely trigger the replacement time alert (rrt) on some devices. as of february 12, 2016, medtronic states that it has observed an occurrence rate of 0.45% of the devices that experience this problem, leading to the occurrence of possible serious adverse events on the patient.


  • Modelo / Serial
  • Descripción del producto
    The REVEAL LINQ cardiac monitor from MEDTRONIC is a programmable device that continuously monitors the ECG and other physiological parameters of the patient. The device registers cardiac in response to the activation of the patient and the arrhythmias that have been detected automatically. It is indicated in the following cases: Patients with clinical syndromes osituations with greater risk of cardiac arrhythmias. Patients who experience transient symptoms that may suggest cardiac arrhythmia.
  • Manufacturer


  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source